Cleared Traditional

K062892 - EUKARE

K062892 is an FDA 510(k) clearance for EUKARE, manufactured by Eumed Biotechnology Co., Ltd.. The device is a Class 2 Chemistry device with product code CGA cleared through the Traditional 510(k) pathway after a 118-day FDA review.

K062892 · Eumed Biotechnology Co., Ltd. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2007
Decision
118d
Days
Class 2
Risk

K062892 is an FDA 510(k) clearance for the EUKARE. Classified as Glucose Oxidase, Glucose (product code CGA), Class II - Special Controls.

Submitted by Eumed Biotechnology Co., Ltd. (Hsin Chu City, TW). The FDA issued a Cleared decision on January 22, 2007 after a review of 118 days - within the typical 510(k) review window.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1345 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Eumed Biotechnology Co., Ltd. devices

FDA 510(k) Submission Details - K062892

510(k) Number K062892 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 26, 2006
Decision Date January 22, 2007
Days to Decision 118 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
30d slower than avg
Panel avg: 88d · This submission: 118d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CGA Device Classification - Class 2, Special Controls

Product Code CGA Glucose Oxidase, Glucose
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1345
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CGA Glucose Oxidase, Glucose

All 286
Devices cleared under the same product code (CGA) and FDA review panel - the closest regulatory comparables to K062892.
NOVA STATSTRIP XPRESS GLUCOSE HOSPITAL METER SYSTEM
K070960 · Nova Biomedical Corp. · Jul 2007
GLUCO TRACK BLOOD GLUCOSE MONITORING SYSTEM
K062799 · Apex BioTechnology Corp. · Feb 2007
NOVA STATSTRIP GLUCOSE HOSPITAL METER SYSTEM
K063821 · Nova Biomedical Corp. · Jan 2007
EASYGLUCO, MODEL IGM-0002 G2
K061431 · U. S. Diagnostics, Inc. · Jan 2007
SELFCHECK GLUCO
K061528 · Card Guard Scientific Survival , Ltd. · Sep 2006
EASYPLUS SELF MONITORING GLUCOSE TEST SYSTEM, MODEL EPS04014
K061992 · Eps Bio Technology Corp. · Sep 2006